Literature DB >> 2242525

Airway hyperresponsiveness in patients with microvascular angina. Evidence for a diffuse disorder of smooth muscle responsiveness.

R O Cannon1, D B Peden, C Berkebile, W H Schenke, M A Kaliner, S E Epstein.   

Abstract

Anginal chest pain in patients with angiographically normal coronary arteries may be caused by a limited coronary flow response to stress because of abnormal function of the coronary microcirculation (microvascular angina). Studies of forearm arterial function suggested that patients with microvascular angina may have a diffuse disorder of smooth muscle tone. Because dyspnea is common in these patients and seems disproportionate to the severity of myocardial ischemia, we studied air flow (forced expiratory volume in 1 second, or FEV1) in the basal state and after methacholine inhalation to determine whether bronchial smooth muscle is affected in this syndrome. Five of 36 patients with microvascular angina had a basal FEV1 of less than 70% of that predicted and did not receive methacholine. Of the remaining 31 patients, 14 (45%) had a more-than-20% reduction in FEV1 after methacholine inhalation (as much as 25 mg/ml), a response significantly greater than that of nine patients with heart disease (0%, p less than 0.025) and 24 normal volunteers of similar age and gender distribution (13%, p less than 0.025). Furthermore, the product of the methacholine dose inhaled and the magnitude of decline in FEV1 from baseline (methacholine response score) was significantly lower in patients with microvascular angina than in normal volunteers (16 +/- 8.6 versus 22.2 +/- 3.7, p = 0.026). We conclude that airway hyperresponsiveness is frequently demonstrable in patients with microvascular angina; these findings are consistent with our hypothesis that this syndrome may represent a more generalized abnormality of vascular and nonvascular smooth muscle function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242525     DOI: 10.1161/01.cir.82.6.2011

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries.

Authors:  J Sztajzel; F Mach; A Righetti
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

2.  Syndrome X: radionuclide studies of myocardial perfusion in patients with chest pain and normal coronary arteriograms.

Authors:  S D Rosen; P G Camici
Journal:  Eur J Nucl Med       Date:  1992

Review 3.  Cardiac syndrome X and microvascular coronary dysfunction.

Authors:  Erika Jones; Wafia Eteiba; Noel Bairey Merz
Journal:  Trends Cardiovasc Med       Date:  2012-09-29       Impact factor: 6.677

Review 4.  Recent developments in microvascular angina.

Authors:  O Ali; F W Smart; T Nguyen; H Ventura
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

5.  Decreased serum osteoprotegerin levels in patients with cardiac syndrome X.

Authors:  A Altun; B Ugur-Altun; E Tatli
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

6.  Pulmonary microvascular permeability and gas exchange in patients with syndrome X.

Authors:  G Durmus-Altun; Sa Vardar; Ys Salihoglu; M Aktoz; B Dirlik; A Altun
Journal:  Hippokratia       Date:  2012-04       Impact factor: 0.471

7.  Chest Pain Characteristics in Cardiac Syndrome X Compared to Coronary Artery Disease.

Authors:  Ramaze Farouke Elhakeem; Mohamed Faisal Lutfi; Ahmed Babiker Mohamed Ali; Mohamed Yusif Sukkar
Journal:  Open Access Maced J Med Sci       Date:  2019-07-25

8.  Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study.

Authors:  Amela Kabaklić; Zlatko Fras
Journal:  Arch Med Sci       Date:  2017-06-12       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.